Dr Ronit Pressler has worked at Great Ormond Street Hospital (GOSH) since 2008 and is currently the clinical lead of the EEG-video telemetry unit and an Honorary Senior Lecturer at UCL Great Ormond Street Institute of Child Health.
“Working at GOSH is rewarding and inspiring because of the children, their families and my colleagues. I aim to provide a high-quality neurophysiology service with an ongoing commitment to research to improve the outcome of children with epilepsy.” Dr Ronit Pressler
• Presurgical evaluation of children with complex epilepsy
• Effect of EEG changes on cognition and behaviour
• Neonatal EEG
• Qualified from Berlin University
• Trained in Paediatrics in Berlin,
• Trained in Clinical Neurophysiology at GOSH and the National Hospital for Neurology and Neurosurgery, London
• MRCPCH, Royal College of Paediatrics and Child Health
• MD at Free University Berlin
• CCT in Clinical Neurophysiology, London
• PhD University of London
• Chair of the ILAE taskforce on neonatal seizures (part of ILAE Commission on Classification & Terminology)
• Co-ordinator of NEMO
Ronit Pressler is currently the co-ordinator for a large European funded program investigating the safety and efficacy of bumetanide for the treatment of seizures in babies. The project is known as NEMO: Treatment of Neonatal seizures with Medication Off-patent).
• Neonatal seizures, particularly their diagnosis and treatment
• The effect of epilepsy on cognition
• Pre-surgical evaluation in children with complex epilepsy
Ronit Pressler has written numerous peer-reviewed articles including:
Pressler, R. M., Boylan, G. B., Marlow, N., Blennow, M., Chiron, C., Cross, J,H., de Vries, L. S., Hallberg, B., Hellström-Westas, L., Jullien, V., Livingstone, V., Mangum, B, Murphy, B., Murray, D., Pons, G., Rennie, J., Swarte, R., Toet, M, C., Vanhatalo, S., Zohar, S., 2015. Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial. Lancet Neurol. 14(5) pp. 469-77.
Japaridze, N., Muthuraman, M., Reinicke, C., Moeller, F., Anwar, A.R., Mideksa, K.G., Pressler, R., Deuschl, G., Stephani, U., Siniatchkin, M., 2015. Neuronal Networks during Burst Suppression as Revealed by Source Analysis. PLoS One. 10(4).
Chan, H.W., Pressler, R., Uff, C., Gunny, R., St Piers, K., Cross, H., Bamber, J., Dorward, N., Harkness, W., Chakraborty, A., 2014. A novel technique of detecting MRI-negative lesion in focal symptomatic epilepsy: intraoperative ShearWave elastography. Epileppsia. 55(4) pp. e30-3.
Rosenzweig, I., Fogarasi, A., Johnsen, B., Alving, J., Fabricius, M.E., Scherg, M., Neufeld, M.Y., Pressler, R.,Kjaer, T.W., van Emde Boas, W., Beniczky, S., 2014. Beyond the double banana: improved recognition of temporal lobe seizures in long-term EEG. J Clin Neurophysiol. 31(1) pp. 1-9.
Beniczky, S., Hirsch, L.J., Kaplan, P.W., Pressler, R., Bauer, G., Aurlien, H., Brøgger, J.C., Trinka, E., 2013. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia. 54 (Suppl 6) pp. 28-9.
Coppola, A., Tostevin, A., McTague, A., Pressler, R.M., Cross, J.H., Sisodiya, S.M., 2013. Myoclonic epilepsy in a child with 17q22-q23.1 deletion. Am J Med Genet A. 161A (8) pp. 2036-9.
Boylan, G.B., Pressler, R.M., 2013. Neonatal seizures: the journey so far. Semin Fetal Neonatal Med. 18(4) pp. 173-4.
Pressler, R.M., Mangum, B., 2013. Newly emerging therapies for neonatal seizures. Semin Fetal Neonatal Med. 18(4) pp. 216-223.
Pressler, R., Auvin, S., 2013. Comparison of Brain Maturation among Species: An Example in Translational Research Suggesting the Possible Use of Bumetanide in Newborn. Front Neurol. 15(4) p. 36.
Pressler, R.M., 2012. Vagus nerve stimulation in children with intractable epilepsy. Dev med Child Neurol54(9) pp. 782-3.
转诊您的孩子至Ronit Pressler 医生